RediNews
ETFs Holding PCYC »    PCYC Historical Stock Prices »
PCYC News Video: Thu, Mar 5, 2015, 1:37 PM — Thursday's ETF Movers: BBH, ILF


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Pharmacyclics is a biopharmaceutical company that designs, develops and commercializes therapies with a focus on product candidates that are small-molecule drugs for the treatment of cancer and immune-mediated diseases. Co.'s IMBRUVICA™ product has been developed for mantle cell lymphoma and chronic lymphocytic leukemia patients, who in each case have received at least one prior therapy. Co. also has three other product candidates in clinical development, including a Bruton's tyrosine kinase inhibitor targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa (PCI-27483), and a histone deacetylase inhibitor targeting in solid tumors and hematological malignancies. Self directed investors in Pharmacyclics, Inc. will be interested in keeping up with all Pharmacyclics, Inc. news they can find, both PCYC news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on PCYC. At RediNews, we simplify this task by presenting both PCYC news releases originating from Pharmacyclics, Inc. itself, and PCYC news from a variety of media outlets. Visitors can browse this news online and through our PCYC RSS news feed.

PCYC News

PCYC News — Articles, Videos, & Press Releases

PCYC is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

ACHN News
CHE News
AMSG News
ARTC News
VAR News
PMC News
EBS News
A News
HMSY News
SGYP News

Suppose you have experience with web publishing content and are starting a new financial website. You will have a stock index table with every major stock index you can think of, at the top you have the current market time and whether the markets are open or closed, and then you have a quote box where users can enter symbols to get a detailed quote like you would see on an investor relations quote page, along with historical stock quote information either in a stock table or stock market chart graphics. As you design your site, you may have a stock template created once and used for each possible stock ticker symbol, and you may have a stock price panel along the right-hand or left-hand column of other pages of your site. You've got mainly all your basis covered in terms of data, securing a stock market content provider for licensed quote content and historical stock data. But what about news? The same investor relations services providers that provide investor relations content can provide press releases but none of these investor relations tools contain third party articles. While third party articles can sometimes be critical of companies, that's what you want when looking for financial portal content, because corporate relations content designed for investor relations quotes pages is concerned with eliminating negativity and controversy. But third party news articles are critical for websites whose readers want to read all the news about the stocks they own, both published by the company and published by third parties. It is for this reason that RSS feeds by RediNews can add a compelling piece of additional dynamic content to your website. Look for the RSS icon on any news page within RediNews (which will look like this): to access our free RSS-based news feeds to supplement your web content.

PCYC News | www.RediNews.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.